Protara Therapeutics, Inc. Profile Avatar - Palmy Investing

Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell thera…

Biotechnology
US, New York [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of TARA's Analysis
CIK: 1359931 CUSIP: 74365U107 ISIN: US74365U1079 LEI: - UEI: -
Secondary Listings
TARA has no secondary listings inside our databases.